{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:15:27Z","timestamp":1763442927881,"version":"3.45.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>In non-obese type 2 diabetes (T2DM) patients, the incidence of metabolic dysfunction associated fatty liver disease (MAFLD) is very insidious and easily overlooked in clinical examinations. The aim of our article is to explore whether the serum uric acid to High-density lipoprotein cholesterol (HDL-C) ratio (UHR) can be used for independent assessment of the risk of MAFLD in non-obese T2DM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>1622 T2DM patients were analyzed, and 506 non-obese patients were ultimately included in the study. Routine clinical and laboratory date were collected. In the non-obese T2DM population, the stability of UHR in predicting MAFLD was evaluated through subgroup analysis, and compared UHR with other indicators. Finally, we used logistic regression and established a nomogram model to assess the diagnostic efficacy of UHR for MAFLD. To evaluate the nomogram\u2019s predictive performance, we employed a suite of techniques including receiver operating characteristic (ROC) analysis, calibration curve assessment, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>As UHR levels increased, the prevalence of MAFLD gradually increased in non-obese T2DM patients. Logistic regression indicated that UHR was associated with MAFLD in non-obese T2DM participants. We constructed a nomogram model using UHR, 2 hour postprandial glucose (2h-PG), 2 hour C-Peptide (2hC-P), body mass index (BMI), triglycerides (TG), serum creatinine (CRE), and C-reactive protein (CRP) as predictive factors to estimate the probability of developing MAFLD in non-obese T2DM subjects. The clinical utility of the model was supported by its strong performance on both the calibration curve and DCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In non-obese T2DM patients, the morbidity rate of MAFLD was significantly higher in high level UHR subjects than that in low level UHR subjects. in non-obese T2DM patients, the nomogram model constructed based on UHR, BMI, 2h-PG, 2hC-P, TG, CRE, and CRP had good predictive ability for the risk of MAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1608929","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:13:03Z","timestamp":1763442783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of serum uric acid to high-density lipoprotein cholesterol ratio for MAFLD in non-obese type 2 diabetes patients based on nomogram"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuehan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sixu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2784537","article-title":"Nonalcoholic fatty liver disease cirrhosis: A review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis","volume":"2018","author":"Li","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B4","unstructured":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management\n          \n          25477264"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbacli.2014.09.001","article-title":"Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients","volume":"3","author":"Goh","year":"2015","journal-title":"BBA Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19069","article-title":"Extrahepatic manifestations of nonalcoholic fatty liver disease","volume":"14","author":"Li","year":"2020","journal-title":"Gut Liver"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.08.008","article-title":"Lean non-alcoholic fatty liver disease","volume":"38","author":"Wang","year":"2019","journal-title":"Clin Nutr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120562","article-title":"Lean patients with non-alcoholic fatty liver disease have a severe histological phenotype similar to obese patients","volume":"7","author":"Denkmayr","year":"2018","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2527","article-title":"Serum uric acid levels and risk of metabolic syndrome: A dose-response meta-analysis of prospective studies","volume":"100","author":"Yuan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0154345","DOI":"10.1371\/journal.pone.0154345","article-title":"Association between triglyceride to HDL-C ratio (TG\/HDL-C) and insulin resistance in chinese patients with newly diagnosed type 2 diabetes mellitus","volume":"11","author":"Ren","year":"2016","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20201005","article-title":"The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study","volume":"67","author":"Kosekli","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12876-022-02263-4","article-title":"Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels","volume":"22","author":"Zhu","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","article-title":"Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity","volume":"15","author":"Fracanzani","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/dia.2013.0165","article-title":"Comparison of characteristics between nonobese and overweight\/obese subjects with nonalcoholic fatty liver disease in a South Indian population","volume":"16","author":"Vendhan","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2174\/1871530318666181116111945","article-title":"Diabetes association with liver diseases: an overview for clinicians","volume":"19","author":"Hamed","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/2513175","article-title":"Relationship between uric acid to high density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease in nonoverweight\/obese patients with type 2 diabetes","volume":"2023","author":"Cui","year":"2023","journal-title":"Int J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s1590-8658(02)80194-3","article-title":"POLI.ST.E.N.A. Study Group. Policentrica Steatosi Epatica Non Alcolica. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study","volume":"34","author":"Lonardo","year":"2002","journal-title":"Dig Liver Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2019.5965\/2018","article-title":"Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"111","author":"Fern\u00e1ndez Rodr\u00edguez","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.11.021","article-title":"Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study","volume":"50","author":"Li","year":"2009","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-017-0531-5","article-title":"Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults","volume":"16","author":"Zheng","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac190","article-title":"Serum uric acid levels and nonalcoholic fatty liver disease: A 2-sample bidirectional mendelian randomization study","volume":"107","author":"Li","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","article-title":"Association between hyperuricemia and insulin resistance","volume":"24","author":"Abreu","year":"2011","journal-title":"Acta Med Port"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.03.001","article-title":"A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity","volume":"182","author":"Kontush","year":"2005","journal-title":"Atherosclerosis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-13-100","article-title":"Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile","volume":"13","author":"Corey","year":"2014","journal-title":"Lipids Health Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i24.3009","article-title":"Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease","volume":"25","author":"Mato","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116089","article-title":"A large-scale study on uric acid-related biomarkers in patients with bipolar disorder","volume":"339","author":"Gao","year":"2024","journal-title":"Psychiatry Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1002\/edm2.446","article-title":"Serum uric acid to high-density lipoprotein ratio as a novel indicator of inflammation is correlated with the presence and severity of metabolic syndrome: A large-scale study","volume":"6","author":"Kolahi Ahari","year":"2023","journal-title":"Endocrinol Diabetes Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12944-021-01457-1","article-title":"LDL\/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study","volume":"20","author":"Zou","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12944-021-01573-y","article-title":"Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study","volume":"20","author":"Zou","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12944-020-01421-5","article-title":"Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study","volume":"19","author":"Yang","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12944-021-01479-9","article-title":"The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population","volume":"20","author":"Sheng","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12944-020-01419-z","article-title":"Association between the alanine aminotransferase\/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study","volume":"19","author":"Zou","year":"2020","journal-title":"Lipids Health Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1608929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:13:04Z","timestamp":1763442784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1608929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":44,"alternative-id":["10.3389\/fendo.2025.1608929"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1608929","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"article-number":"1608929"}}